Clinical Trials

How do we move on from a sombre start to 2016?

See how thermodynamics can be used to improve your lead optimization process.

Advanced digital technologies are sweeping through the world and changing the way we live our lives and do business.

This application note describes how and when can kinetic information be retrieved from ITC power curves.

Clinical development is outmoded; we are witnessing serious attrition in cancer R&D. Perhaps it’s time to live and die by the mantra: “no biomarker, no trial”.

Despite clinical failures in the 1990s, pharma is (cautiously) ready to try again with oral peptide formulations.

Drug makers and regulators are taking steps towards transparency, but is it enough?

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.

The techniques of laser diffraction and automated particle imaging support the fast, cost-effective development of nasal spray products, simultaneously providing the data required for regulatory compliance. This paper examines their application.

Taylor Dispersion measurements are used to monitor self-association and oligomeric state in a variety of buffer conditions.